<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>6(6)</volume><submitter>Wang C</submitter><funding>Shanghai Municipal Health Commission</funding><funding>National Science Fund for Distinguished Young Scholars</funding><funding>National Natural Science Foundation of China</funding><funding>National Postdoctoral Program for Innovative Talents</funding><pubmed_abstract>Resective surgery is an effective approach for long-term seizure control in drug-resistant focal epilepsy when the epileptic focus (EF) can be accurately delineated and removed. However, intraoperative mapping of EF with electrocorticography is laborious, time-consuming, and highly vulnerable to the effects of anesthesia. Here, we demonstrated that activated microglia can be reliable biomarkers for EF localization. Leveraging a newly developed ratiometric Raman nanosensor, ultraHOCls, we successfully visualize proinflammatory microglia in live epileptic mice, allowing for precise EF delineation without the interference of anesthesia. Compared to electrocorticography-guided surgery, ultraHOCl-guided surgery results in a substantial 61% reduction in total seizure burden in epileptic mouse mo</pubmed_abstract><journal>Cell reports. Medicine</journal><pagination>102155</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12208331</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Ultrabright ratiometric Raman-guided epilepsy surgery by intraoperatively visualizing proinflammatory microglia.</pubmed_title><pmcid>PMC12208331</pmcid><pubmed_authors>Zhang J</pubmed_authors><pubmed_authors>Wang C</pubmed_authors><pubmed_authors>Wang D</pubmed_authors><pubmed_authors>Wang J</pubmed_authors><pubmed_authors>Wang L</pubmed_authors><pubmed_authors>Jiang Y</pubmed_authors><pubmed_authors>Ding Y</pubmed_authors><pubmed_authors>Xie F</pubmed_authors><pubmed_authors>Zheng H</pubmed_authors><pubmed_authors>Wang Q</pubmed_authors><pubmed_authors>Chen Y</pubmed_authors><pubmed_authors>Zhao J</pubmed_authors><pubmed_authors>Zheng F</pubmed_authors><pubmed_authors>Mao Y</pubmed_authors><pubmed_authors>Yan K</pubmed_authors><pubmed_authors>Li C</pubmed_authors><pubmed_authors>Fan Z</pubmed_authors><pubmed_authors>Chen M</pubmed_authors><pubmed_authors>Chen L</pubmed_authors><pubmed_authors>Xiao X</pubmed_authors><pubmed_authors>Sun W</pubmed_authors><pubmed_authors>Zhou X</pubmed_authors><pubmed_authors>Guan Y</pubmed_authors><pubmed_authors>Li Z</pubmed_authors><pubmed_authors>Lei Z</pubmed_authors><pubmed_authors>Hu J</pubmed_authors><pubmed_authors>Cai Z</pubmed_authors><pubmed_authors>Zhu X</pubmed_authors><pubmed_authors>Duan W</pubmed_authors></additional><is_claimable>false</is_claimable><name>Ultrabright ratiometric Raman-guided epilepsy surgery by intraoperatively visualizing proinflammatory microglia.</name><description>Resective surgery is an effective approach for long-term seizure control in drug-resistant focal epilepsy when the epileptic focus (EF) can be accurately delineated and removed. However, intraoperative mapping of EF with electrocorticography is laborious, time-consuming, and highly vulnerable to the effects of anesthesia. Here, we demonstrated that activated microglia can be reliable biomarkers for EF localization. Leveraging a newly developed ratiometric Raman nanosensor, ultraHOCls, we successfully visualize proinflammatory microglia in live epileptic mice, allowing for precise EF delineation without the interference of anesthesia. Compared to electrocorticography-guided surgery, ultraHOCl-guided surgery results in a substantial 61% reduction in total seizure burden in epileptic mouse mo</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jun</publication><modification>2026-06-01T16:01:47.528Z</modification><creation>2026-04-08T14:04:23.756Z</creation></dates><accession>S-EPMC12208331</accession><cross_references><pubmed>40449482</pubmed><doi>10.1016/j.xcrm.2025.102155</doi></cross_references></HashMap>